
Syensqo Acquires Azerys, a Natural Rosemary Extraction Company
Syensqo has completed the acquisition of a controlling stake in Azerys, a specialist in rosemary extraction with assets in El Jadida, Morocco.

Syensqo has completed the acquisition of a controlling stake in Azerys, a specialist in rosemary extraction with assets in El Jadida, Morocco.

In a move to enter the activated carbon market for micropollutants removal, Finnish chemicals company Kemira has agreed to purchase Norit’s UK reactivation business from Purton Carbons. The deal is expected to close in the third quarter of2024. Financial details of the deal were not disclosed.

South Korea-headquartered contract development and manufacturing organization (CDMO) SK Bioscience plans to acquire a 60% stake in IDT Biologika, a German CDMO specialized in vaccines, gene and immune therapy and oncolytic viruses, from Klocke Group. Klocke will retain a 40% stake in IDT Biologika and thus remains the company's second-largest shareholder.

AbbVie has acquired Celsius Therapeutics, a privately held biotechnology company developing new therapies inflammatory diseases, for $250 million in cash. The transaction is subject to certain customary adjustments.

In a move to enhance its chemistry, manufacturing and controls (CMC) capabilities, UK-based process research and development contract research organization (CRO) CatSci has acquired chromatography provider Reach Separations. Financial details of the transaction were not disclosed.

DuPont has signed an agreement to acquire US medical device contract manufacturer Donatelle Plastics. The transaction is expected to close in the third quarter 2024, subject to satisfaction of customary closing conditions and receipt of regulatory approvals. Financial details of the deal were not disclosed.

Dow has signed an agreement to acquire US company Circulus, a recycler of plastic waste into post-consumer resin (PCR). The transaction includes two facilities, one in Ardmore, Oklahoma, and another in Arab, Alabama, with a total capacity of 50,000 metric tons per year. Dow expects the transaction to close in the third quarter of 2024, subject to customary regulatory approval.

Japan’s Shin-Etsu Chemical has made an offer to acquire all of the shares in its affiliate Mimasu Semiconductor Industry for ¥68.0 billion (approximately $430.9 million). Shin-Etsu will raise its stake in Mimasu to 100% from the current 43.87%. The tender offer will begin on June 21, with the aim of closing by the end of Aug. 5.

Zofingen, Switzerland-based contract development and manufacturing organization (CDMO) Siegfried has signed a binding agreement to acquire an early-phase CDMO site in Grafton, Wisconsin, US, from Curia. The transaction is expected to close by July 1, subject to customary closing conditions.

In a move to continue its geographical expansion, Hamburg-based German distributor Biesterfeld has acquired Aerontec, a South African supplier and distributor of advanced composite materials and related technology.

In a move to expand its expertise and business in silicone-coated healthcare products, Germany’s Wacker Chemie has acquired the manufacturing assets and know-how of US-based Bio Med Sciences. As part of the acquisition, a majority of Bio Med Sciences’ workforce will also move to Wacker, the company said. Financial details of the transaction were not disclosed.

LyondellBasell (LYB) has completed the acquisition of a 35% interest in Saudi Arabia-based National Petrochemical Industrial Company (Natpet) from Alujain. The transaction was announced in January of this year.

US oil and gas giant ConocoPhillips has reached a definitive agreement to acquire Marathon Oil for $22.5 billion, including net debt of $5.4 billion. The transaction, which is subject to the approval of Marathon Oil stockholders, regulatory clearance and other customary closing conditions, is expected to close in the fourth quarter of 2024.

US drugmaker Merck & Co. (MSD) has agreed to acquire privately held ophthalmology-focused biotechnology company Eyebiotech (EyeBio).

US healthcare giant Johnson & Johnson (J&J) agreed to acquire Yellow Jersey Therapeutics (YJT) from biotechnology company Numab Therapeutics in an all-cash transaction valued at approximately $1.25 billion, giving it worldwide rights to the novel, investigational bispecific antibody NM26.

Biogen and Human Immunology Biosciences (HI-Bio), a privately-held clinical-stage biotechnology company focused on targeted therapies for patients with severe immune-mediated diseases (IMDs), have entered into a definitive agreement. Biogen has agreed to acquire HI-Bio for $1.15 billion (€1.06 billion) upfront and up to $650 million (€600.5 million) in potential milestone payments.

Genmab has completed its $1.8 billion acquisition of ProfoundBio, a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs) and ADC technologies for the treatment of cancers.

H.B. Fuller Company, the biggest pureplay adhesives company in the world, has acquired ND Industries, a leading provider of specialty adhesives and fastener locking and sealing solutions serving customers in the automotive, electronics, aerospace, and other industries.

US specialty chemicals producer Ashland has signed a definitive agreement to sell its nutraceuticals business to Turnspire Capital Partners. The transaction is expected to close in the third quarter of 2024, subject to customary closing conditions. Financial details of the transaction were not given.

Ineos Oxide and LyondellBasell have completed the sale of LyondellBasell’s Ethylene Oxide & Derivatives (EO&D) business and associated production facilities located in Bayport, Texas to Ineos.

Swiss drugmaker Novartis agreed to acquire Mariana Oncology, a US biotechnology company based in Watertown, Massachusetts, that develops novel radioligand therapies (RLTs) for the treatment of cancer.

Japan’s Ono Pharmaceutical agreed to acquire US cancer-therapy company Deciphera Pharmaceuticals for approximately $2.4 billion. Deciphera focuses on innovative cancer therapeutics, and specializes in kinase biology.

Arkema agreed to acquire Dow’s flexible packaging laminating adhesives business, a leading producer in this market with annual sales of approximately $250 million (€233 million). This acquisition will expand Arkema’s flexible packaging solutions portfolio, positioning the group as a key player in the industry.

Syensqo announced the acquisition of JinYoung Bio, a specialty cosmetic ingredients supplier based in South Korea. This investment expands Syensqo’s portfolio toward more natural and high-value specialty skin care solutions with functional and active ingredients.

Kühne Holding has agreed to purchase Aenova Group, a pharma contract development and manufacturing organization (CDMO), from BC Partners. BC will reinvest and retain a minority stake in Aenova. The financial terms remain undisclosed.

Saudi Arabia’s state-owned oil giant Aramco has entered into discussions with Hengli Group regarding the potential acquisition of a 10% stake in Hengli Petrochemical, subject to due diligence and required regulatory clearances.

Sumitomo Chemical has announced to divest all of its shares in two of its flat panel display (FPD) process chemical subsidiaries in China to Zhenjiang Runjing High Purity Chemical Technology (Runjing Tech). The transaction is expected to be completed by the end of May this year. Financial details of the transaction were not disclosed.

Arkema is set to acquire a 78% stake in Proionic, a start-up specializing in ionic liquids production. These components are crucial for future lithium-ion batteries. This acquisition expands Arkema’s solutions and strengthens its position in the materials sector across various battery technologies.

Following regulatory approval of the deal, Italian chemical company Versalis has completed the acquisition of compounder Tecnofilm.

US-based Vertex Pharmaceuticals has agreed to pay approximately $4.9 billion in cash to acquire Alpine Immune Sciences, a compatriot biotechnology company focused on discovering and developing innovative, protein-based immunotherapies.

DKSH has announced the signing of an agreement to acquire Malaysia's Elite Organic Sdn. Bhd. This acquisition allows DKSH Performance Materials to enhance its capabilities in the promising pharmaceutical, food, and nutraceutical markets across the Asia Pacific region.

German distribution giant Brenntag announced the acquisition of Lawrence Industries, an independent specialties distributor in the UK. The transaction, Brenntag said, further strengthens the company’s position within Material Science and across the coatings, adhesives, sealants and elastomers (CASE), construction, polymer and rubber industries. Financial details of the deal were not disclosed.

Azelis continues its acquisition spree, this time adding Indonesian distributor PT Marga Dwi Kencana (MDK) to its portfolio. Financial details of the deal were not disclosed.

Danish drugmaker Genmab has agreed to buy privately-owned US biotechnology company ProfoundBio for $1.8 billion. ProfoundBio develops novel ADCs and ADC technologies for the treatment of certain cancers, including ovarian cancer and other FRα-expressing solid tumors.

Clariant, a specialty chemical company, announced it has completed the acquisition of Lucas Meyer Cosmetics, a provider of high-value ingredients for the cosmetics and personal care industry, from IFF for an Enterprise Value (EV) of $810 million (€746 million). The purchase price will be subject to customary net debt and working capital adjustments.
























